Doug Schenkel
Stock Analyst at Wolfe Research
(3.61)
# 865
Out of 4,749 analysts
67
Total ratings
53.06%
Success rate
32.22%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TEM Tempus AI | Initiates: Outperform | $60 | $57.39 | +4.55% | 1 | Dec 13, 2024 | |
HOLX Hologic | Initiates: Peer Perform | n/a | $72.14 | - | 5 | Dec 13, 2024 | |
TWST Twist Bioscience | Initiates: Outperform | $60 | $52.37 | +14.57% | 2 | Dec 13, 2024 | |
STVN Stevanato Group | Initiates: Outperform | $28 | $22.41 | +24.94% | 1 | Dec 13, 2024 | |
WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $341.55 | - | 1 | Dec 13, 2024 | |
RGEN Repligen | Initiates: Peer Perform | n/a | $166.21 | - | 1 | Nov 14, 2024 | |
MRVI Maravai LifeSciences Holdings | Initiates: Peer Perform | n/a | $4.93 | - | 1 | Nov 14, 2024 | |
DHR Danaher | Upgrades: Outperform | $285 | $222.74 | +27.95% | 2 | Oct 31, 2024 | |
BRKR Bruker | Downgrades: Peer Perform | n/a | $58.15 | - | 2 | Sep 30, 2024 | |
A Agilent Technologies | Downgrades: Peer Perform | n/a | $151.52 | - | 8 | Jun 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $50 | $44.64 | +12.01% | 2 | Jun 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $15.00 | - | 3 | Jun 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $132.74 | - | 5 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $56.05 | - | 4 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $597.75 | - | 3 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $12.67 | - | 1 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $126.13 | - | 1 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.54 | - | 1 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $22.28 | - | 1 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $46.98 | - | 2 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $176.92 | - | 3 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $415.48 | - | 1 | Dec 13, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.50 | - | 1 | Aug 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.71 | - | 1 | Aug 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.47 | - | 1 | Aug 9, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $19.82 | - | 1 | Jun 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.50 | - | 1 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.39 | - | 1 | Dec 29, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.68 | - | 1 | Jul 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $4.19 | +329.59% | 1 | Jun 19, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $37.06 | - | 2 | Mar 28, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $278.38 | -67.67% | 2 | Feb 22, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $9.19 | - | 1 | Jan 2, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $218.02 | - | 1 | Nov 1, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $86.83 | -81.57% | 2 | Sep 28, 2017 |
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $57.39
Upside: +4.55%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $72.14
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $52.37
Upside: +14.57%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $22.41
Upside: +24.94%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $341.55
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $166.21
Upside: -
Maravai LifeSciences Holdings
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $4.93
Upside: -
Danaher
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $222.74
Upside: +27.95%
Bruker
Sep 30, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $58.15
Upside: -
Agilent Technologies
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $151.52
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $50
Current: $44.64
Upside: +12.01%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $15.00
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $132.74
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $56.05
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $597.75
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $12.67
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $126.13
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.54
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $22.28
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $46.98
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $176.92
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $415.48
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.50
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.71
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.47
Upside: -
Jun 21, 2021
Initiates: Outperform
Price Target: n/a
Current: $19.82
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.50
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $2.39
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $6.68
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $4.19
Upside: +329.59%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $37.06
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $278.38
Upside: -67.67%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $9.19
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $218.02
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $86.83
Upside: -81.57%